Cargando…
Diclofenac and Meloxicam Exhibited Anti-Virulence Activities Targeting Staphyloxanthin Production in Methicillin-Resistant Staphylococcus aureus
Staphylococcus aureus (S. aureus) is a worldwide leading versatile pathogen that causes a wide range of serious infections. The emergence of antimicrobial resistance against S. aureus resulted in an urgent need to develop new antimicrobials in the new era. The methicillin-resistant S. aureus (MRSA)...
Autores principales: | Elmesseri, Rana A., Saleh, Sarra E., Ghobish, Sarah A., Majrashi, Taghreed A., Elsherif, Heba M., Aboshanab, Khaled M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951919/ https://www.ncbi.nlm.nih.gov/pubmed/36830188 http://dx.doi.org/10.3390/antibiotics12020277 |
Ejemplares similares
-
Staphyloxanthin as a Potential Novel Target for Deciphering Promising Anti-Staphylococcus aureus Agents
por: Elmesseri, Rana A., et al.
Publicado: (2022) -
Photolysis of Staphyloxanthin in Methicillin‐Resistant Staphylococcus aureus Potentiates Killing by Reactive Oxygen Species
por: Dong, Pu‐Ting, et al.
Publicado: (2019) -
Glyceryl trinitrate blocks staphyloxanthin and biofilm formation in Staphylococcus aureus
por: Abbas, Hisham A, et al.
Publicado: (2019) -
Celastrol mitigates staphyloxanthin biosynthesis and biofilm formation in Staphylococcus aureus via targeting key regulators of virulence; in vitro and in vivo approach
por: Yehia, Fatma Al-zahraa A., et al.
Publicado: (2022) -
Small-molecule compound SYG-180-2-2 attenuates Staphylococcus aureus virulence by inhibiting hemolysin and staphyloxanthin production
por: Rao, Lulin, et al.
Publicado: (2022)